Bobby Yanagawa1, Anees Bahji2, Wiplove Lamba3, Darrell H Tan4, Asim Cheema5, Ishba Syed5, Subodh Verma1. 1. Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Toronto. 2. Department of Psychiatry, Queen's University, Kingston. 3. Division of Psychiatry. 4. Division of Infectious Disease. 5. Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE OF REVIEW: The purpose of this article is to provide a brief overview of the medical and surgical management of infective endocarditis secondary to IDU, with a focus on the underlying substance use disorder. RECENT FINDINGS: Patients with infective endocarditis secondary to IDU are often young with unique comorbidities including mental illness, chronic hepatitis C, HIV infection, which are often compounded by limited social and familial supports. The focus of management has been treatment of endocarditis using IV antibiotics alongside surgery. Surgical outcomes compare favorably with those of infective endocarditis in the general population but long-term outcomes of IDUs are significantly worse. This is primarily due to the high rate of recidivism of drug use and the risk of prosthetic valve infective endocarditis. Contemporary management of addiction utilizes an integrative approach, combining both pharmacologic and nonpharmacologic strategies while remaining patient-centered. Given the complexity of care required, we advocate for a multidisciplinary team-based approach including psychiatry, infectious disease, cardiology, cardiac surgery and social services. SUMMARY: Infective endocarditis secondary to IDU remains a medical and surgical challenge with dismal outcomes. Here we offer practical suggestions on the multidisciplinary management of this challenging and high-risk patient cohort.
PURPOSE OF REVIEW: The purpose of this article is to provide a brief overview of the medical and surgical management of infective endocarditis secondary to IDU, with a focus on the underlying substance use disorder. RECENT FINDINGS:Patients with infective endocarditis secondary to IDU are often young with unique comorbidities including mental illness, chronic hepatitis C, HIV infection, which are often compounded by limited social and familial supports. The focus of management has been treatment of endocarditis using IV antibiotics alongside surgery. Surgical outcomes compare favorably with those of infective endocarditis in the general population but long-term outcomes of IDUs are significantly worse. This is primarily due to the high rate of recidivism of drug use and the risk of prosthetic valve infective endocarditis. Contemporary management of addiction utilizes an integrative approach, combining both pharmacologic and nonpharmacologic strategies while remaining patient-centered. Given the complexity of care required, we advocate for a multidisciplinary team-based approach including psychiatry, infectious disease, cardiology, cardiac surgery and social services. SUMMARY:Infective endocarditis secondary to IDU remains a medical and surgical challenge with dismal outcomes. Here we offer practical suggestions on the multidisciplinary management of this challenging and high-risk patient cohort.
Authors: Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner Journal: Ann Thorac Surg Date: 2019-10-17 Impact factor: 4.330
Authors: Lauren M Mitchell; Aimee Milliken; Mary W Montgomery; Steve K Singh; Joji Suzuki Journal: Harv Rev Psychiatry Date: 2020 Sep/Oct Impact factor: 3.732
Authors: Aneta Guzek; Wojciech Braksator; Zbigniew Gąsior; Mariusz Kuśmierczyk; Jacek Różański; Zbigniew Rybicki Journal: Kardiochir Torakochirurgia Pol Date: 2020-04-08
Authors: David Goodman-Meza; Robert E Weiss; Sebastián Gamboa; Abel Gallegos; Alex A T Bui; Matthew B Goetz; Steven Shoptaw; Raphael J Landovitz Journal: BMC Infect Dis Date: 2019-11-08 Impact factor: 3.090
Authors: Thomas D Brothers; Kimiko Mosseler; Susan Kirkland; Patti Melanson; Lisa Barrett; Duncan Webster Journal: PLoS One Date: 2022-01-26 Impact factor: 3.240
Authors: Kristen A Morin; Chad R Prevost; Joseph K Eibl; Michael T Franklyn; Alexander R Moise; David C Marsh Journal: PLoS One Date: 2020-04-24 Impact factor: 3.240